Phenobarbital-Associated Bone Marrow Aplasia: A Case Report and Review of the Literature
Authors:
- Daniele FocosiDFDaniele Focosi
- Richard Eric KastRKRichard Eric Kast
- Edoardo BenedettiEBEdoardo Benedetti
- Federico PapineschiFPFederico Papineschi
- Sara GalimbertiSGSara Galimberti
- Mario PetriniMPMario Petrini
- 29 January 2008
- journal article
- case report
- Published by S. Karger AG in Acta Haematologica
- Vol. 119 (1) , 18-21
Abstract
We report on a 22-year-old female who developed aplastic anemia after administration of phenobarbital for 6 years. Being refractory to steroid and anti-lymphocyte serum, the patient received allogeneic stem cell transplantation, achieving complete remission. We discuss here the potential mechanisms by which phenobarbital and other anti-epileptic drugs can cause aplastic anemia and review the literature for previous case reports and epidemiological studies.Keywords
This publication has 36 references indexed in Scilit:
- Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony‐stimulating factorAmerican Journal of Hematology, 2007
- Risk of Aplastic Anemia in Patients Using Antiepileptic DrugsEpilepsia, 2006
- Pure Red Cell Aplasia after 13 Years of Sodium Valproate, and Bone Marrow Suppression after 17 Years of CarbamazepinePLOS Medicine, 2004
- Pure red cell aplasia during carbamazepine monotherapyBrain and Development, 1997
- Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapyJournal of the Neurological Sciences, 1997
- Aplastic anemia following therapy for absence seizures with ethosuximidePediatric Neurology, 1994
- FelbamateDrugs, 1993
- A Report of a Case with Pure Red Cell Aplasia Induced by Sodium ValproatePediatrics International, 1989
- Analgesic use, blood dyscrasias, and case-control pharmacoepidemiologyJournal of Chronic Diseases, 1987
- A CASE OF APLASTIC ANEMIA AND PANCYTOPENIA WITH TEGRETOL THERAPYHeadache: The Journal of Head and Face Pain, 1969